Genomic and phylogenetic analysis of hepatitis C virus isolates: A survey of 535 strains circulating in Southern France

Journal of Medical Virology

Volumn 71, Issue 3, 2003, Pages 391-398

  Tamalet, Catherine ^a   Colson, Philippe ^a   Tissot Dupont, Hervé ^b   Henry, Mireille ^a   Tourres, Christian ^a   Tivoli, Natacha ^a   Botta, Danielle ^b   Ravaux, Isabelle ^b   Poizot Martin, Isabelle ^c   Yahi, Nouara ^d  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c Hôpital Ste Marguerite   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

5 noncoding region; Epidemiology; HCV genotyping; NS5B region; Phylogenetic analysis; Subtypes

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; FRANCE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRUS GENOME; VIRUS ISOLATION; VIRUS STRAIN;

5' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FRANCE; GENOME, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS; STAPHYLOCOCCUS PHAGE 187; STAPHYLOCOCCUS PHAGE 3A;

EID: 0141869931     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10505     Document Type: Article

References (49)

1. Ackerman Z, Ackerman E, Paltiel O. 2000. Intrafamilial transmission of hepatitis C virus: A systematic review. J Viral Hepatitis 7:93-103.
2. Ansaldi F, Torre F, Bruzzone BM, Picciotto A, Crovari P, Icardi G. 2001. Evaluation ofa new hepatitis C virus sequencing assay as a routine method for genotyping. J Med Virol 63:17-21.
3. Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, Prescott L, Simmonds P. 1996. Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Scand J Infect Dis 28:357-359.
4. Bourliere M, Barberin JM, Rotily M, Guagliardo V, Portal I, Lecomte L, Benali S, Boustiere C, Perrier H, Jullien M, Lambot G, Loyer R, LeBars O, Daniel R, Khiri H, Halfon P. 2002. Epidemiological changes in hepatitis C virus genotypes in France: Evidence in intravenous drug users. J Viral hepatitis 9:62-70.
5. Chen Z, Weck KE. 2002. Hepatitis C virus genotyping: Interrogation of the 5′ untranslated region cannot accurately distinguish genotypes 1a and 1b. J Clin Microbiol 40:3127-3134.
6. Consensus Conference treatment of Hepatitis C. 2002. Gastroenterol Clin Biol 26:B312-B320.
7. Corbet S, Bukh J, Heinsen A, Fomsgaard A. 2003. Hepatitis C virus subtyping by a core-envelope 1-based reverse transcriptase PCR assay with sequencing and its use in determining subtype distribution among Danish patients. J Clin Microbiol 41:1091-1100.
8. Dal Molin G, Ansaldi F, Biagi C, D'Agaro P, Comar M, Crocè L, Tiribelli C, Campello C. 2002. Changing molecular epidemiology of hepatitis C virus infection in northeast Italy. J Med Virol 68:352-356.
9. Davis GL, Lau J. 1997. Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 26(Suppl 1):122S-127S.
10. Desenclos JC, Pillonel J, Delarocque-Astagneau E, de Valk H. 1999. Epidemiologie de l'hépatite C et stratégies de surveillance. Med Mal Infect 29:325-331.
11. Doglio A, Laffont C, Thyss S, Lefebvre JC. 1998. Rapid genotyping of hepatitis C virus by direct cycle sequencing of PCR-amplified cDNAs and capillary electrophoresis analysis. Res Virol 149:219-227.
12. Dubois F, Desenclos JC, Mariotte N, Goudeau A, and the Collaborative Study Group. 1997. Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution, and risk factors. Hepatology 25:1490-1496.
13. El-Zayadi A, Simmonds P, Dabbous H, Prescott L, Selim O, Ahdy A. 1996. Response to interferon α of Egyptian patients infected with hepatitis C virus genotype 4. J Viral Hepatitis 3:261-264.
14. Felsenstein J. 1992. PHYLIP: Phylogeny inference package. Version 3.5. Seattle: Department of Genetics, University of Washington.
15. Gerken G, Rothaar T, Rumi MG, Soffredini R, Trippler M, Blunk MJ, Butcher A, Soviero S, Colucci G. 2000. Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination. J Clin Microbiol 38:2210-2214.
16. Germer JF, Rys PN, Thorvilson JN, Persing DH. 1999. Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol 37:2625-2630.
17. Halfon P, Riflet H, Renou C, Quentin Y, Cacoub P. 2001. Molecular evidence of male-to-female sexual transmission of hepatitis C virus after vaginal and anal intercourse. J Clin Microbiol 39:1204-1206.
18. Halfon P, Trimoulet P, Bourliere M, Khiri H, de Ledhingen V, Couzigou P, Feryn JM, Alcaraz P, Renou C, Fleury HJ, Ouzan D. 2001. Hepatitis C virus genotyping based on 5′noncoding sequence analysis (Trugene). J Clin Microbiol 39:1771-1773.
19. Halfon P, Roubicek C, Gerolami V, Quentin Y, Khiri H, Pepe G, Berland Y. 2002. Use of phylogenetic analysis of hepatitis C virus (HCV) hypervariable region 1 sequences to trace an outbreak of HCV in an autodialysis unit. J Clin Microbiol 40:1541-1545.
20. Irish DN, Blake C, Christophers J, Craske JE, Burnapp L, Abbs IC, MacMahon EM, Muir P, Banatvala JE, Simmonds P. 1999. Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: Implications for infection control and laboratory screening. J Med Virol 59:135-140.
21. Izopet J, Pasquier C, Sandres K, Puel J, Rostaing L. 1999. Molecular evidence for nosocomial transmission of hepatitis C virus in a French Hemodialysis unit. J Med Virol 58:139-144.
22. Jeanmougin F, Thompson JD, Gouy M, Higgins DJ, Gibson TJ. 1999. Multiple sequence alignment with clustal X. Trends Biochem Sci 23:403-405.
23. Kalinina O, Norder H, Vetrov T, Zhdanov K, Barzunova M, Plotnikova V, Mukomölov S, Magnius LO. 2001. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use, J Med Virol 65:517-524.
24. Le Pogam S, Le Chapois D, Christen R, Dubois F, Barin F, Goudeau A. 1998. Hepatitis C in a haemodialysis unit: Molecular evidence for nosocomial transmission. J Clin Microbiol 36:3040-3043.
25. Lee SC, Antony A, Lee N, Leibow J, Yang JQ, Soviero S, Gutekunst K, Rosenstraus M. 2000. Improved version 2.0 qualitative and quantitative AMPLICROR reverse transcription-PCR tests for hepatitis C virus RNA: Calibration to international units, enhanced genotype reactivity, and performance characteristics. J Clin Microbiol 38:4171-4179.
26. Martinot-Peignoux M, Roudot-Thoraval F, Mendel I, Coste J, Izopet J, Duverlie G, Payan C, Pawlotsky JM, Defer C, Bogard M, Gerolami V, Halfon P, Buisson Y, Fouqueray B, Loiseau P, Lamoril J, Lefrere JJ, Marcellin P, and the GEMHEP. 1999. Hepatitis C virus genotypes in France: Relationship with epidemiology, pathogenicity, and response to interferon therapy. J Viral Hepatitis 6:435-443.
27. Mc Hutchinson JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK. 1998. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis C Interventional Therapy Group. N Engl J Med 339:1485-1492.
28. Mondelli MU, Silini E. 1999. Clinical significance of hepatitis C virus genotypes. J Hepatol 31(Suppl 1):65-70.
29. Morice Y, Roulot D, Grando V, Stirnemann J, Gault E, Jeantils V, Bentata M, Jarrousse B, Lortholary O, Pallier C, Dény P. 2001. Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol 82:1001-1012.
30. Norder H, Bergström A, Uhnoo I, Aldén J, Weiss L, Czajkowski J, Magnius L. 1998. Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region. J Clin Microbiol 36:3066-3069.
31. Pawlowtsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D. 1995. Relationship between Hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 171:1607-1610.
32. Pol S, Thiers V, Nousbaum JB, Legendre C, Berthelot P, Kreis H, Brechot C. 1995. The changing relative prevalence of hepatitis C virus genotypes: Evidence in hemodialyzed patients and kidney recipients. Gastroenterology 108:581-583.
33. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J. 1998. Randomised trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 352:1426-1432.
34. Poynard T, McHutchinson GJG, Ling Z, Albrecht MH, for the ALGORVIRC project group. 2000. Is an "A la carte" combination interferon alpha 2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C. Hepatology 31:211-218.
35. Quarleri JF, Robertson BH, Mathet VL, Feld M, Espinola L, Requeijo MP, Mando O, Carballal G, Oubina JR. 2000. Genomic and phylogenetic analysis of hepatitis C virus isolates from Argentine patients: A six-year retrospective study. J Clin Microbiol 38:4560-4568.
36. Rosen HR, Chou S, Sasaki AW, Gretch DR. 1999. Molecular epidemiology of hepatitis C infection in U.S veteran liver transplant recipients: Evidence for decreasing relative prevalence of genotype 1b. Am J Gastroenterol 94:3015-3019.
37. Ross RS, Viazov SO, Holtzer CD, Beyou A, Monnet A, Mazure C, Roggendorf M. 2000. Genotyping of hepatitis C virus isolates using CLIP sequencing. J Clin Microbiol 38:3581-3584.
38. Ross RS, Viazov S, Renzing-Köhler K, Roggendorf M. 2000. Changes in the epidemiology of hepatitis C infection in Germany: Shift in the predominance of hepatitis C subtypes. J Med Virol 60:122-125.
39. Roudot-Thoraval F. 2000. Epidémiologie de l'hépatite C. Med Mal Infect 30:27-33.
40. Sanchez Quijano A, Abad MA, Torrenteras R, Rey C, Pineda JA, Leal M, Macias J, Lissen E. 1997. Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol 27:25-29.
41. Simmonds P. 1995. Variability of hepatitis C virus. Hepatology 21:570-583.
42. Simmonds P. 1999. Viral heterogeneity of hepatitis C virus. J Hepatol 31(Suppl 1):54-60.
43. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS, Choo QL, Colombo M, Cuypers T, Date T, Dusheiko G, Esteban JI, Fay O, Hadziyannis S, Han J, Hatzakis A, Holmes EC, Hotta H, Houghton M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Lelie PN, Maertens G, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesink HW, Rice C, Roggendorf M, Schalm S, Shikata T, Shimotohno K, Stuyver L, Trépo C, Weiner A, Yap PL, Urdea M. 1994. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
44. Smith DB, Mellor J, Jarvis LM, Davidson F, Kolberg J, Urdea M, Yap PL, Simmonds P, and the International HCV Collaborative Study Group. 1995. Variation of the hepatitis C virus 5′-coding region: Implications for secondary structure, virus detection, and typing. J Gen Virol 76:1749-1761.
45. Stuyver L, Van Arnhem W, Wyseur A, Hernandez F, Delaporte E, Maertens G. 1994. Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes. Proc Natl Acad Sci USA 91:10134-10138.
46. Stuyver L, Van Arnhem W, Hernandez F, Maertens G. 1996. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 34:2259-2266.
47. Thomson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 1997. The clustal X windows interface: Flexible strategies for multiple sequence alignments aided by quality analysis tools. Nucleic Acids Res 24:4876-4882.
48. Widell A, Shev S, Mansson S, Zhang YY, Foberg U, Norkrans A, Frydon A, Weilana O, Kurkus J, Nordenfelt E. 1994, Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: Epidemiological applications. J Med Virol 44:272-279.
49. Zein NN. 2000. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13:223-235.